Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial

Record identifier

TN_cdi_proquest_journals_2519268885

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2519268885

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial

Full title

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2021, Vol.22 (5), p.632-642

Record Identifier

TN_cdi_proquest_journals_2519268885

Language

English

Formats

Publication information

Publisher

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_journals_2519268885

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2519268885

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card